Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Linda_Powers
|
| gptkbp:clinicalTrialPhase |
DCVax-L for glioblastoma
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
oncology
immunotherapy |
| gptkbp:foundedYear |
1996
|
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:Bethesda,_Maryland,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Northwest Biotherapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
DCVax-Direct
DCVax-L |
| gptkbp:specializesIn |
personalized cancer vaccines
|
| gptkbp:stockSymbol |
NWBO
|
| gptkbp:tradedOn |
gptkb:OTCQB
|
| gptkbp:website |
https://www.nwbio.com/
|
| gptkbp:bfsParent |
gptkb:Linda_Powers
|
| gptkbp:bfsLayer |
8
|